Immune microenvironment composition in high-grade serous ovarian cancers based on BRCA mutational status.
Sara CorvignoJared K BurksWei HuYanping ZhongNicholas B JenningsNicole D FlemingShannon N WestinBryan FellmanJinsong LiuAnil K SoodPublished in: Journal of cancer research and clinical oncology (2021)
This study reveals substantial differences between the immune microenvironment composition of germline BRCA-mutated and BRCA wild-type HGSC.